The experimental oral therapy VQ-101 can successfully restore a critical cellular function in people with a genetic form of Parkinson’s disease, the treatment’s developer, Vanqua Bio, has announced. One month […] The post VQ-101 restores enzyme lacking in GBA-linked Parkinson’s: Early trial appeared first on Parkinson's News Today.| Parkinson's News Today – The Web's Daily Resource for Parkinson's News